These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 13719572)

  • 21. [The effect of griseofulvin on cultures of embryonal fibroblasts and human bone marrow].
    ALBRECHT M
    Arzneimittelforschung; 1962 Mar; 12():282-5. PubMed ID: 13860167
    [No Abstract]   [Full Text] [Related]  

  • 22. [EFFECTS OF DEXTRAN AND POLYVINYLPYRROLIDONE ON NORMAL MASTOCYTES CULTIVATED IN VITRO].
    BAECKELAND E
    C R Seances Soc Biol Fil; 1964; 158():904-7. PubMed ID: 14186980
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention by calciphylaxis of the progeria-like syndrome induced by chronic dihydrotachysterol overdosage.
    SELYE H; STREBEL R
    Proc Soc Exp Biol Med; 1962; 110():673-6. PubMed ID: 13910525
    [No Abstract]   [Full Text] [Related]  

  • 24. IRON-DEXTRAN complex.
    J Am Med Assoc; 1958 Mar; 166(12):1482-3. PubMed ID: 13513389
    [No Abstract]   [Full Text] [Related]  

  • 25. THE EFFECT OF A LATHYROGEN ON SULFATE METABOLISM IN CULTURES OF THE STRAIN L FIBROBLAST.
    BICKLEY HC; ORBISON JL
    Lab Invest; 1964 Feb; 13():172-81. PubMed ID: 14161667
    [No Abstract]   [Full Text] [Related]  

  • 26. THE EFFECT OF DIHYDROTACHYSTEROL AND FERRIC DEXTRAN ON THE TEETH AND PERIODONTIUM OF THE RAT.
    RATCLIFF PA; ITOKAZU H
    J Oral Ther Pharmacol; 1964 Jul; 1():7-22. PubMed ID: 14204419
    [No Abstract]   [Full Text] [Related]  

  • 27. [Dextran and dextran-derivatives].
    Görlich B
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1969 Jun; 39(7):149-67. PubMed ID: 5395997
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of massive iron overload in the rat.
    GOLDBERG L; SMITH JP; MARTIN LE
    Nature; 1957 Apr; 179(4562):734. PubMed ID: 13418773
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of iron-dextran infusion on veins.
    Newcombe R
    Med J Aust; 1967 Mar; 1(10):491-3. PubMed ID: 6020723
    [No Abstract]   [Full Text] [Related]  

  • 30. [Current knowledge of the presumed carcinogenic power of the iron-dextran complex (Imferon)].
    LAYRISSE M
    Rev Obstet Ginecol Venez; 1961; 21():307-13. PubMed ID: 14463059
    [No Abstract]   [Full Text] [Related]  

  • 31. [TREATMENT OF ANEMIC DONORS WITH IRON-DEXTRAN].
    TERAHATA K
    Iryo; 1964 Jul; 18():487-8. PubMed ID: 14196274
    [No Abstract]   [Full Text] [Related]  

  • 32. [3. COLLATERAL EFFECTS OF THE INTRAMUSCULAR ADMINISTRATION OF IRON-DEXTRAN].
    BERGAMI
    Ann Sanita Pubblica; 1964; 25():1182-5. PubMed ID: 14260486
    [No Abstract]   [Full Text] [Related]  

  • 33. THE TREATMENT OF IRON-DEFICIENCY ANEMIA WITH INTRAVENOUS IRON DEXTRAN.
    MARCHASIN S; WALLERSTEIN RO
    Blood; 1964 Mar; 23():354-8. PubMed ID: 14130446
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental studies on the cancerogenic effect of iron dextran (ursoferran)].
    KUNZ J; SHAHAB L; HENZE K; DAVID H
    Acta Biol Med Ger; 1963; 10():602-14. PubMed ID: 13927395
    [No Abstract]   [Full Text] [Related]  

  • 35. The tissue response to iron-dextran; an electron-microscope study.
    MUIR AR; GOLBERG L
    J Pathol Bacteriol; 1961 Oct; 82():471-82. PubMed ID: 14477013
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of some purine analogs on the growth of H.E.p. No. 1 and chick embryo fibroblast cells.
    RICH MA; PEREZ AG; EIDINOFF ML
    Cancer Res; 1962 Jan; 22():3-9. PubMed ID: 14491911
    [No Abstract]   [Full Text] [Related]  

  • 37. [Research on the in vivo carcinogenic activity of an iron-dextran complex in the rat].
    VIALLIER J; REBOUILLAT M
    C R Seances Soc Biol Fil; 1962; 156():691-3. PubMed ID: 13925738
    [No Abstract]   [Full Text] [Related]  

  • 38. REACTIONS TO INTRAVENOUS IRON DEXTRAN.
    SEFTEL HC
    Br Med J; 1965 Mar; 1(5435):657. PubMed ID: 14245189
    [No Abstract]   [Full Text] [Related]  

  • 39. THE RISK OF SARCOMATOUS CHANGE AFTER IRON-DEXTRAN THERAPY.
    CHANDRA RK
    Indian J Pediatr; 1965 Feb; 32():75-7. PubMed ID: 14281290
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on iron-dextran complex.
    KARLEFORS T; NORDEN A
    Acta Med Scand Suppl; 1958; 342():1-54. PubMed ID: 13626533
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.